Jazz Sparks On Its New Plan To Take On Roche; Hint: It's In Cancer

Jazz stock bounced off its buy zone Tuesday after the FDA approved its drug, Ziihera, to treat a form of stomach cancer. The post Jazz Sparks On Its New Plan To Take On Roche; Hint: It's In Cancer appeared first on Investor's Business Daily.